share_log

DBV Technologies Shares Are Trading Higher After the Company Announced 3-year Results From Its IPITOPE Phase 3 Open-label Extension Study.

Benzinga ·  Jan 9 05:10
DBV Technologies Shares Are Trading Higher After the Company Announced 3-year Results From Its IPITOPE Phase 3 Open-label Extension Study.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment